Učitavanje...
Budesonide and fluticasone propionate differentially affect the airway epithelial barrier
BACKGROUND: COPD patients have a higher risk of pneumonia when treated with fluticasone propionate (FP) than with placebo, and a lower risk with budesonide (BUD). We hypothesized that BUD and FP differentially affect the mucosal barrier in response to viral infection and/or cigarette smoke. METHODS:...
Spremljeno u:
| Izdano u: | Respir Res |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704248/ https://ncbi.nlm.nih.gov/pubmed/26739349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0318-z |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|